Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

International standards for tuberculosis care.

Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC.

Lancet Infect Dis. 2006 Nov;6(11):710-25. Review.

PMID:
17067920
2.

Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.

Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):42-6.

PMID:
16885778
3.

Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients.

Lopez-Cortes LF, Marin-Niebla A, Lopez-Cortes LE, Villanego I, Rodriguez-Diez M, Pascual-Carrasco R.

Int J Tuberc Lung Dis. 2005 Dec;9(12):1385-90.

PMID:
16466062
4.

Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.

Burman W, Benator D, Vernon A, Khan A, Jones B, Silva C, Lahart C, Weis S, King B, Mangura B, Weiner M, El-Sadr W; Tuberculosis Trials Consortium..

Am J Respir Crit Care Med. 2006 Feb 1;173(3):350-6.

PMID:
16109981
6.

Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals?

Dlodlo RA, Fujiwara PI, Enarson DA.

Eur Respir J. 2005 Apr;25(4):751-7. Review.

7.

Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.

Dheda K, Lampe FC, Johnson MA, Lipman MC.

J Infect Dis. 2004 Nov 1;190(9):1670-6.

8.

A nested case-control study on treatment-related risk factors for early relapse of tuberculosis.

Chang KC, Leung CC, Yew WW, Ho SC, Tam CM.

Am J Respir Crit Care Med. 2004 Nov 15;170(10):1124-30.

PMID:
15374844
9.

Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.

Nettles RE, Mazo D, Alwood K, Gachuhi R, Maltas G, Wendel K, Cronin W, Hooper N, Bishai W, Sterling TR.

Clin Infect Dis. 2004 Mar 1;38(5):731-6.

10.

Clinical management of tuberculosis in the context of HIV infection.

de Jong BC, Israelski DM, Corbett EL, Small PM.

Annu Rev Med. 2004;55:283-301. Review.

PMID:
14746522
11.

Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.

Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC.

AIDS. 2003 Dec 5;17(18):2615-22.

PMID:
14685055
12.
13.

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society..

Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62. No abstract available.

PMID:
12588714
14.

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.

Benator D, Bhattacharya M, Bozeman L, Burman W, Cantazaro A, Chaisson R, Gordin F, Horsburgh CR, Horton J, Khan A, Lahart C, Metchock B, Pachucki C, Stanton L, Vernon A, Villarino ME, Wang YC, Weiner M, Weis S; Tuberculosis Trials Consortium..

Lancet. 2002 Aug 17;360(9332):528-34.

PMID:
12241657
15.
16.
17.

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL.

AIDS. 2002 Jan 4;16(1):75-83.

PMID:
11741165
18.
19.
20.

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection.

Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A, Ippolito G; Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)..

AIDS. 2000 Sep 8;14(13):1985-91.

PMID:
10997404
Items per page

Supplemental Content

Support Center